GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...
bernama3d
Shingles May Cause Long-Term Pain In Older People – Expert
PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...
Monthly Prescribing Reference1d
GSK Reports Findings on Coadministered RSV and Shingles Vaccines
Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...
Medscape2d
Varicella and Varicella-Zoster Vaccine
The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zoster vaccine for immunocompetent adults 60 years of age and older, based on the results of this study ...
The Pharma Letter1d
Good signs for co administration of GSK’s RSV and shingles vaccines
UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...
American States Ranked by the Highest and Lowest Vaccination Rates
Rhode Island has the highest vaccination rate across the country, while Mississippi was found to have the lowest, a new study ...
Man, 55, develops rare flesh-eating disease after contracting common childhood virus
A man in Saudi Arabia diagnosed with shingles suffered a rare and potentially life-threatening infection that ate away the ...
Global mpox emergency: debunking fact versus fiction
Outbreak in several African countries has sparked the spread of disinformation online about symptoms, transmission and ...